BETHESDA, Md—The National Institutes of Health will convene a consensus development conference on adjuvant therapy for breast cancer on November 1–3, 2000.

The meeting will consider new information on chemotherapy, hormonal therapy, and other treatment aspects, including the clinical use of prognostic markers and quality-of-life issues. A panel of experts from outside NIH will make recommendations after hearing 2 days of presentations by leading researchers. The last breast cancer consensus conference on adjuvent therapy was in 1990.